Skip to main content
Premium Trial:

Request an Annual Quote

Beckman, Orchid Patent Suit Against Sequenom is Dismissed

NEW YORK (GenomeWeb News) – A patent infringement suit filed a year ago by Beckman Coulter and Orchid Cellmark against Sequenom has been dismissed, Sequenom disclosed in a filing with US Securities and Exchange Commission today.

Sequenom said that on June 22, the parties filed a stipulation of dismissal with the US District Court for the Southern District of California in which the claims made by Beckman and Orchid were dismissed, as were the counterclaims by Sequenom. The parties agreed to bear their own attorneys' fees and costs.

The suit was filed on June 5, 2008, and alleged that Sequenom was infringing three US patents held by Orchid and licensed to Beckman. Specifically, the plaintiffs had claimed that Sequenom's MassArray iPlex products for SNP genotyping applications were infringing the three patents — US Nos. 5,888,819; 6,004,744; and 6,537,748. Beckman Coulter sells the GenomeLab SNPstream Genotyping System, a competing platform.

Sequenom said that the dismissal came after a Markman hearing held on June 11. The San Diego-based firm also said that it is not required to make any payments to Beckman Coulter or Orchid, and it was not required to take a license to the patents.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.